WINDTREE THERAPEUTICS INC /DE/ Foreign Currency Transaction Loss, before Tax
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Foreign Currency Transaction Loss, before Tax of $300.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2023-03-31
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction loss, before tax for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction loss, before tax for the quarter ending 2021-09-30 was $100.00K, a 66.67% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction loss, before tax for the quarter ending 2021-06-30 was $300.00K, a 40.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction loss, before tax for the quarter ending 2020-12-31 was $600.00K.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction loss, before tax for fiscal 2021 was $300.00K, a 75.00% decline from fiscal 2020.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction loss, before tax for fiscal 2020 was $1.20M.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month | Foreign Currency Transaction Loss, before Tax 9 month | Foreign Currency Transaction Loss, before Tax 12 month | Foreign Currency Transaction Loss, before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $100.00K derived: sum of 2 quarters · filed 2023-03-31 | $400.00K derived: sum of 3 quarters · filed 2023-03-31 | $300.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-14 | $400.00K derived: sum of 2 quarters · filed 2022-11-14 | $300.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-11 | $200.00K 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $900.00K derived: sum of 2 quarters · filed 2022-03-31 | $1.40M derived: sum of 3 quarters · filed 2022-03-31 | $1.20M 10-K · filed 2022-03-31 | $1.14M 10-K · filed 2021-03-29 |
| 2020-09-30 | $300.00K 10-Q · filed 2021-11-10 | $800.00K derived: sum of 2 quarters · filed 2021-11-10 | $600.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $500.00K 10-Q · filed 2021-08-05 | $300.00K 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |